- Home
- WHWK vs VATE Comparison
WHWK vs VATE Comparison
Compare WHWK & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- VATE
- Stock Information
- Founded
- WHWK 2007
- VATE 1994
- Country
- WHWK United States
- VATE United States
- Employees
- WHWK N/A
- VATE N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- WHWK Health Care
- VATE Industrials
- Exchange
- WHWK Nasdaq
- VATE Nasdaq
- Market Cap
- WHWK 87.6M
- VATE 70.3M
- IPO Year
- WHWK N/A
- VATE 1996
- Fundamental
- Price
- WHWK $1.94
- VATE $5.34
- Analyst Decision
- WHWK
- VATE
- Analyst Count
- WHWK 0
- VATE 0
- Target Price
- WHWK N/A
- VATE N/A
- AVG Volume (30 Days)
- WHWK 148.4K
- VATE 17.6K
- Earning Date
- WHWK 08-15-2025
- VATE 08-06-2025
- Dividend Yield
- WHWK N/A
- VATE N/A
- EPS Growth
- WHWK N/A
- VATE N/A
- EPS
- WHWK 0.91
- VATE N/A
- Revenue
- WHWK $27,775,000.00
- VATE $1,066,100,000.00
- Revenue This Year
- WHWK $49.83
- VATE N/A
- Revenue Next Year
- WHWK N/A
- VATE N/A
- P/E Ratio
- WHWK $2.24
- VATE N/A
- Revenue Growth
- WHWK 16.51
- VATE N/A
- 52 Week Low
- WHWK $1.21
- VATE $3.25
- 52 Week High
- WHWK $3.81
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- WHWK N/A
- VATE 45.53
- Support Level
- WHWK N/A
- VATE $5.23
- Resistance Level
- WHWK N/A
- VATE $5.76
- Average True Range (ATR)
- WHWK 0.00
- VATE 0.24
- MACD
- WHWK 0.00
- VATE 0.04
- Stochastic Oscillator
- WHWK 0.00
- VATE 41.67
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.